JinMed reported financial results for the fiscal year ended September 30, 2025. Net income attributable to shareholders was USD 1.19 million, reflecting a 67.6 percent decrease for the period. Net income reached USD 1.38 million for the year. The income tax provision stood at USD 0.76 million, representing an increase of 122.2 percent. JinMed primarily generates revenue from the design and manufacture of wheelchair products, wheelchair components, and other living aids, including oxygen concentrators, bath aids, and rehabilitative devices. The company’s products are distributed in Japan, China, and other international markets. For the period, the net income attributed to non-controlling interest was USD 0.19 million, a 2.74 times increase. JinMed highlighted continued focus on providing solutions for people with disabilities, the elderly, and those in recovery, through its portfolio of manual wheelchairs and related healthcare products.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jin Medical International Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-013870), on February 10, 2026, and is solely responsible for the information contained therein.